These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 2877928)
1. Adrenergic control of lipolysis and metabolic responses in obesity. Zahorska-Markiewicz B; Kucio C; Piskorska D Horm Metab Res; 1986 Oct; 18(10):693-7. PubMed ID: 2877928 [TBL] [Abstract][Full Text] [Related]
2. Lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462. Saulnier-Blache JS; Taouis M; Dauzats M; Uzan A; Berlan M; Lafontan M J Pharmacol Exp Ther; 1989 Dec; 251(3):1187-92. PubMed ID: 2574742 [TBL] [Abstract][Full Text] [Related]
3. Yohimbine administration prevents over-responsiveness to epinephrine induced by simulated microgravity. Berlan M; Verhaeghe S; Pavy-Le Traon A; Thalamas C; Lafontan M; Marques MA; Senard JM; Parent M; Galitzky J Aviat Space Environ Med; 2002 Aug; 73(8):735-42. PubMed ID: 12182212 [TBL] [Abstract][Full Text] [Related]
4. [Adrenergic lipolysis in human fat cells: properties and physiological role of alpha-adrenergic receptors (author's transl)]. Berlan M; Lafontan M; Dang Tran L J Physiol (Paris); 1980; 76(2):133-46. PubMed ID: 6249915 [TBL] [Abstract][Full Text] [Related]
5. Does yohimbine act as a slimming drug? Kucio C; Jonderko K; Piskorska D Isr J Med Sci; 1991 Oct; 27(10):550-6. PubMed ID: 1955308 [TBL] [Abstract][Full Text] [Related]
6. Activation of antilipolytic alpha(2)-adrenergic receptors by epinephrine during exercise in human adipose tissue. Stich V; de Glisezinski I; Crampes F; Suljkovicova H; Galitzky J; Riviere D; Hejnova J; Lafontan M; Berlan M Am J Physiol; 1999 Oct; 277(4):R1076-83. PubMed ID: 10516247 [TBL] [Abstract][Full Text] [Related]
7. Changes in lipolytic sensitivity following repeated epinephrine infusion in humans. Townsend RR; Klein S; Wolfe RR Am J Physiol; 1994 Feb; 266(2 Pt 1):E155-60. PubMed ID: 8141272 [TBL] [Abstract][Full Text] [Related]
8. Alpha-2 adrenergic antilipolytic effect in dog fat cells: incidence of obesity and adipose tissue localization. Berlan M; Carpene C; Lafontan M; Dang-Tran L Horm Metab Res; 1982 May; 14(5):257-60. PubMed ID: 6284627 [TBL] [Abstract][Full Text] [Related]
9. Dynamic strength training improves insulin sensitivity and functional balance between adrenergic alpha 2A and beta pathways in subcutaneous adipose tissue of obese subjects. Polak J; Moro C; Klimcakova E; Hejnova J; Majercik M; Viguerie N; Langin D; Lafontan M; Stich V; Berlan M Diabetologia; 2005 Dec; 48(12):2631-40. PubMed ID: 16273345 [TBL] [Abstract][Full Text] [Related]
10. Regulation of human lipolysis. In vivo observations on the role of adrenergic receptors. Burns TW; Mohs JM; Langley PE; Yawn R; Chase GR J Clin Invest; 1974 Jan; 53(1):338-41. PubMed ID: 4808646 [TBL] [Abstract][Full Text] [Related]
11. [Lack of efficacy of yohimbine in the treatment of obesity]. Berlin I; Stalla-Bourdillon A; Thuillier Y; Turpin G; Puech AJ J Pharmacol; 1986; 17(3):343-7. PubMed ID: 3795978 [TBL] [Abstract][Full Text] [Related]
12. Adrenergic control of lipolysis in women compared with men. Schmidt SL; Bessesen DH; Stotz S; Peelor FF; Miller BF; Horton TJ J Appl Physiol (1985); 2014 Nov; 117(9):1008-19. PubMed ID: 25190743 [TBL] [Abstract][Full Text] [Related]
13. The primary amine metabolite of sibutramine stimulates lipolysis in adipocytes isolated from lean and obese mice and in isolated human adipocytes. Richardson DK; Jones RB; Bailey CJ Horm Metab Res; 2006 Nov; 38(11):727-31. PubMed ID: 17111299 [TBL] [Abstract][Full Text] [Related]
14. [Influence of alpha or beta adrenergic antagonists on catecholamine dependent metabolic effects in pigs]. Brenner KV; Gürtler H Acta Biol Med Ger; 1981; 40(12):1759-66. PubMed ID: 6125073 [TBL] [Abstract][Full Text] [Related]
15. Effect of endurance training on adrenergic control of lipolysis in adipose tissue of obese women. Richterova B; Stich V; Moro C; Polak J; Klimcakova E; Majercik M; Harant I; Viguerie N; Crampes F; Langin D; Lafontan M; Berlan M J Clin Endocrinol Metab; 2004 Mar; 89(3):1325-31. PubMed ID: 15001629 [TBL] [Abstract][Full Text] [Related]
16. Adrenergic modulation of human pancreatic polypeptide (hPP) release. Sive AA; Vinik AI; Levitt N Gastroenterology; 1980 Oct; 79(4):665-72. PubMed ID: 6997131 [TBL] [Abstract][Full Text] [Related]
17. Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects. Lorenzi M; Karam JH; Tsalikian E; Bohannon NV; Gerich JE; Forsham PH J Clin Invest; 1979 Feb; 63(2):310-7. PubMed ID: 34629 [TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y in obese women during treatment with adrenergic modulation drugs. Zahorska-Markiewicz B; Obuchowicz E; Waluga M; Tkacz E; Herman ZS Med Sci Monit; 2001; 7(3):403-8. PubMed ID: 11386016 [TBL] [Abstract][Full Text] [Related]
19. Acute effect of L-796568, a novel beta 3-adrenergic receptor agonist, on energy expenditure in obese men. van Baak MA; Hul GB; Toubro S; Astrup A; Gottesdiener KM; DeSmet M; Saris WH Clin Pharmacol Ther; 2002 Apr; 71(4):272-9. PubMed ID: 11956510 [TBL] [Abstract][Full Text] [Related]
20. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits. Knudtzon J Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]